Actos Direct Buyers Say Drug Mix Patent Can't Block Generic

Direct buyers of the diabetes drug Actos on Friday asked to file an amicus brief in the Second Circuit appeal of an antitrust suit against Takeda, saying it should not be...

Already a subscriber? Click here to view full article